Therapeutic HIV Vaccine Trials
نویسندگان
چکیده
منابع مشابه
Willingness to Participate in HIV Therapeutic Vaccine Trials among HIV-Infected Patients on ART in China
BACKGROUND More and more HIV therapeutic vaccines will enter clinical trials; however, little is known about the willingness to participate (WTP) in HIV therapeutic vaccine trials among HIV-positive individuals. OBJECTIVE To investigate the WTP in HIV therapeutic vaccine trials among Chinese HIV-infected patients. METHODS We conducted a cross-sectional survey on HIV-positive inpatients and ...
متن کاملLessons learned from human HIV vaccine trials
PURPOSE OF REVIEW The ability to induce broadly neutralizing antibody (bNAb) responses is likely essential for development of a globally effective HIV vaccine. Unfortunately, human vaccine trials conducted to date have failed to elicit broad plasma neutralization of primary virus isolates. Despite this limitation, in-depth analysis of the vaccine-induced memory B-cell repertoire can provide val...
متن کاملAccelerating HIV-1 Vaccine Efficacy Trials
Despite major advances in HIV-1 therapeutics and prevention strategies, the development of a safe and effective prophylactic HIV-1 vaccine will likely be critical for ending the global HIV-1 epidemic. Yet only four HIV-1 vaccine concepts have been tested for clinical efficacy over the past 30 years. In this Commentary, we describe key hurdles facing the HIV-1 vaccine development field and outli...
متن کاملWhat can HIV vaccine trials teach us about future HIV vaccine dissemination?
This investigation explored commonalities and differences in barriers and motivators to HIV vaccine trial participation and acceptability of future U.S. Food and Drug Administration (FDA)-approved HIV vaccines in order to identify implications of clinical trials for future HIV vaccine dissemination. Fifteen focus groups were conducted with 157 predominately ethnic minority and low income partic...
متن کاملEpigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
Epigraph is an efficient graph-based algorithm for designing vaccine antigens to optimize potential T-cell epitope (PTE) coverage. Epigraph vaccine antigens are functionally similar to Mosaic vaccines, which have demonstrated effectiveness in preliminary HIV non-human primate studies. In contrast to the Mosaic algorithm, Epigraph is substantially faster, and in restricted cases, provides a math...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Bioanalysis & Biomedicine
سال: 2013
ISSN: 1948-593X
DOI: 10.4172/1948-593x.1000e115